Hans-Peter Gerber

Hans-Peter Gerber

Company: 3T Biosciences

Job title: Chief Scientific Officer


Identification of Novel pHLA Targets for Solid Tumor Targeting with Cancer Vaccines 9:30 am

• Advantages of intracellular targets (pHLAs) versus viral, neoantigens or conventional cell surface antigens • Strategies to find the most prevalent and immunogenic pHLA targets in tumors from CPI responders • Selection of self-antigen targets with highest tumor vs normal ratios to avoid off-tumor, on-target toxicitiesRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.